Maiken Keson-Brookes - CLO & Corp. Secretary at Rubius Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CLO & Corp. Secretary
Issuer Symbol
RUBY
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Maiken Keson-Brookes since 09 Mar 2025

Holdings reported by Maiken Keson-Brookes for Rubius Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 143,750 31 Jan 2022 Direct Common Stock
Restricted Stock Units 34,500 31 Jan 2022 Direct Common Stock
Common Stock 5,343 01 Feb 2022 Direct

Transactions reported by Maiken Keson-Brookes for Rubius Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.